Daily First efficacy trial of Athersys stem cell therapy yields disappointing interim results. So what now? By
Pharma Stem cell company Athersys eyes potential new opportunities for its stroke therapy in Japan By
Pharma Stem cell firm Athersys faces enrollment struggles with one Phase 2 study; readies to begin another By
MedCity Influencers Athersys gets OK for German solid organ transplant clinical trial By Brandon Glenn
